首页> 外文期刊>Free radical research >GANRA-5 protects mice from X-ray irradiation-induced dysfunction of the immune system
【24h】

GANRA-5 protects mice from X-ray irradiation-induced dysfunction of the immune system

机译:GANRA-5保护小鼠免受X射线辐射诱发的免疫系统功能障碍

获取原文
获取原文并翻译 | 示例
       

摘要

Ionizing radiation produces reactive oxygen species (ROS), which cause damage to cells. We have synthesized a class of ROS scavengers and found that one of them, named GANRA-5, exhibits high radio-protective effects against both heavy ion irradiation and X-rays, while at the same time displaying low levels of toxicity. Pre-administration with an effective dose of GANRA-5 reduces radiation-induced damage to tissues and increases the survival rate of exposed mice. In this study, we evaluated the changes to the immune system via X-ray irradiation, and investigated how pre-administration of GANRA-5 exhibited preventative characteristics. Compared to the irradiated control groups, GANRA-5 treatment significantly reduced the radiation-induced spleen shrinkage and pathological changes. Moreover, pretreatment with GANRA-5 significantly (p < 0.01) enhanced the cellular immune response, which was characterized by higher peritoneal macrophage as well as splenocyte survival, and a higher ratio of CD4(+)/CD8(+) T lymphocytes. In addition, GANRA-5 treatment before whole body irradiation significantly improved the humoral response (p < 0.01) as indicated by the higher antibody titers of IgG, IgA, and IgM. Furthermore, GANRA-5 treatment significantly (p < 0.01) countered radiation-induced decreases in the titers of serum IL-2 and IL-4 when compared to irradiated but untreated control groups. In summary, these findings indicate that GANRA-5 provides effective protection to the immune system against X-ray-induced immunosuppression.
机译:电离辐射会产生活性氧(ROS),这会损坏细胞。我们合成了一类ROS清除剂,发现其中一个名为GANRA-5,对重离子辐射和X射线均显示出高辐射防护作用,同时显示出低水平的毒性。预先服用有效剂量的GANRA-5可减少辐射诱导的组织损伤,并提高暴露小鼠的存活率。在这项研究中,我们评估了通过X射线照射对免疫系统的变化,并研究了GANRA-5的预给药如何表现出预防性特征。与辐照对照组相比,GANRA-5治疗显着减少了辐射诱发的脾脏萎缩和病理变化。此外,用GANRA-5预处理可显着增强(p <0.01)细胞免疫反应,其特征是腹膜巨噬细胞和脾细胞存活率更高,CD4(+)/ CD8(+)T淋巴细胞比例更高。另外,全身抗体辐照前的GANRA-5处理可显着改善体液反应(p <0.01),如IgG,IgA和IgM的抗体滴度更高。此外,与辐照但未治疗的对照组相比,GANRA-5治疗显着(p <0.01)抵消了辐射诱导的血清IL-2和IL-4滴度下降。总之,这些发现表明,GANRA-5为免疫系统提供了有效的保护,使其免受X射线诱导的免疫抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号